← All stocks

Viridian Therapeutics, Inc.\DE

VRDN No buying or selling
CIK 0001590750 #1814 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

6 insiders · 0 transactions
1.1×

Stephen Mahoney holds only 1.1 times base salary in stock. $811.69K of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Stephen Mahoney last reported holding, valued at $24.50, the price Common Stock was last bought or sold at on the open market here, on 19 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Fairmount Funds Management LLC entity
Director
5,090,928
$124.73M
+47.7%
Tripuraneni Radhika
Chief Medical Officer
40,000
$980.00K
Mahoney Stephen F.
President and CEO
33,130
$811.69K
+3,213%
Beetham Thomas W.
Chief Operating Officer
13,271
$325.14K
+563.6%
Harmon Seth
Chief Financial Officer
7,790
$190.86K
+115.6%
Tousignant Jennifer
Chief Legal Officer
0
$0.00
−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 2 Nov 2016